Clinical Trials on Stricture; Bowel in Russian Federation

Total 177 results

Burnasyan Federal Medical Biophysical Center

Unknown

Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures

Urethral Strictures in Males

Russian Federation
I.M. Sechenov First Moscow State Medical University

Unknown

Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers

Urethral Stricture

Russian Federation
State Scientific Centre of Coloproctology, Russian...

Unknown

Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease

Russian Federation
Abbott

Completed

Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders

Functional Bowel Disorder

Russian Federation
Moscow State University of Medicine and Dentistry

Recruiting

Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling

Irritable Bowel Syndrome | Inflammatory Bowel Diseases | Healthy Volunteers

Russian Federation
Pirogov Russian National Research Medical University

Recruiting

Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction (COTACSO)

Small Bowel Obstruction | Small Bowel Adhesion | Strangulation of Ileum

Russian Federation
Scientific Center of Children's Health RAMS
Harvard Medical School (HMS and HSDM); University of Alberta

Completed

Predictive Value of pCLE Findings in Pediatric IBD

Inflammatory Bowel Disease

Russian Federation
Research and Practical Clinical Center for Diagnostics...
Sechenov University

Enrolling by invitation

Telemonitoring for IBD Goodness Examination in Russia (TIGE-Rus)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Russian Federation
Federal Stare Budgetary Scientific Institution,...
I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...

Completed

Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Mixed

Russian Federation
Federal Research and Clinical Center of Physical-Chemical...

Unknown

Fecal Microbiota Transplantation for Health Improvement (TFM3) (TFM3)

Irritable Bowel Syndrome | Crohn Disease | Ulcerative Colitis | Irritable Bowel

Russian Federation
Ipsen

Completed

Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy (ESTOS)

Bowel Cleansing

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Inflammatory Bowel Disease and Atherosclerosis Development

Cardiovascular Diseases | Inflammation | Inflammatory Bowel Diseases | Arterial Stiffness

Russian Federation
Vifor Pharma
Parexel

Completed

Maintenance Treatment of Iron Deficiency in IBD Patients (FER-IBD-MAIN)

Iron Deficiency | Inflammatory Bowel Disease

Russian Federation
Vasily Isakov
Russian Science Foundation; Azbuka vkusa; Federal Research Centre of Nutrition...

Completed

Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations (Kombucha)

Irritable Bowel Syndrome With Constipation | Constipation-predominant Irritable Bowel Syndrome

Russian Federation
North-Western State Medical University named after...

Recruiting

Short and Prolonged Conservative Treatment in Patients With Adhesive Intestinal Obstruction

Small Bowel Obstruction | Small Bowel Adhesion

Russian Federation
State Scientific Centre of Coloproctology, Russian...

Completed

Russian Extremely Severe Ulcerative Colitis Study (REXs_UC)

Inflammatory Bowel Diseases | Ulcerative Colitis

Russian Federation
I.M. Sechenov First Moscow State Medical University

Active, not recruiting

Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome

Irritable Bowel Syndrome With Diarrhea

Russian Federation
North-Western State Medical University named after...

Recruiting

Effectiveness of Small Bowel Decompression Techniques in Patients With Small Bowel Obstruction

Small Bowel Obstruction | Small Bowel Obstruction Adhesion | Small-Bowel Obstruction Due to Volvulus | Hernia Incarcerated

Russian Federation
Takeda
Norgine BV

Completed

Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation

Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

Russian Federation, Kazakhstan
Bayer

Terminated

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study (DART)

Skin Disease, Infectious

Russian Federation, Mexico, Singapore
PolyMedix, Inc.

Completed

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA) | (Susceptible or Methicillin Resistant)

Canada, Russian Federation, Ukraine
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Menarini Group

Completed

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) (IRIS)

Irritable Bowel Syndrome

Germany, Denmark, Latvia, Russian Federation, Ukraine, United Kingdom
sigma-tau i.f.r. S.p.A.

Completed

Propionyl-L-Carnitine in Ulcerative Colitis

Ulcerative Colitis

Italy, Lithuania, Poland, Russian Federation
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
Novo Nordisk A/S

Terminated

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Inflammation | Ulcerative Colitis

Poland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
Novartis Pharmaceuticals

Terminated

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

Russian Federation, Czechia, Bulgaria, Germany, Poland, Slovakia
Abbott

Completed

Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation (ROMERUS)

Irritable Bowel Syndrome

Russian Federation
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
Galapagos NV
Gilead Sciences

Terminated

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease (MANTA)

Inflammatory Bowel Disease

United States, Australia, India, Germany, United Kingdom, Russian Federation, New Zealand, Austria, Poland, Romania, Ukraine
Kyowa Kirin, Inc.

Completed

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Digestive System Diseases | Gastrointestinal Diseases | Colonic Diseases | Intestinal Diseases | Abdominal Pain | Inflammatory Bowel Diseases | Ulcerative Colitis | Colitis | Colitis, Ulcerative | Autoimmune Disease

Hungary, Russian Federation, Serbia, United States, Poland, Czechia, Romania
Abbott

Terminated

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

Ulcerative Colitis

United States, Canada, Croatia, Italy, Russian Federation, Spain
Takeda

Completed

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

China, Korea, Republic of, Taiwan, Russian Federation, Turkey, Argentina, Colombia, Mexico, Saudi Arabia, Singapore
Takeda

Completed

A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice (INTENT)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Russian Federation, Belarus, Kazakhstan
Provention Bio, Inc.

Completed

Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease (PRINCE)

Crohn's Disease

Austria, Germany, Hungary, Poland, Russian Federation, Spain, Ukraine
Janssen Research & Development, LLC

Completed

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Inflammation | Crohn's Disease

Belgium, France, Israel, Hungary, Russian Federation, Poland, Canada, United States
EA Pharma Co., Ltd.

Completed

A Study of E6011 in Participants With Active Crohn's Disease

Crohn's Disease

Czechia, Hungary, Japan, Poland, Russian Federation
Galapagos NV

Completed

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis (ORIGIN)

Ulcerative Colitis

Belgium, Czech Republic, Germany, Hungary, Poland, Russian Federation
GlaxoSmithKline

Completed

GSK2982772 Study in Subjects With Ulcerative Colitis

Colitis, Ulcerative

Netherlands, United States, Germany, Russian Federation, Sweden, Poland, United Kingdom
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Crohn's Disease

France, Turkey, Czechia, Greece, Latvia, Hungary, Belarus, Israel, United States, Spain, Bulgaria, Serbia, Croatia, Italy, Germany, India, Japan, Mexico, Moldova, Republic of, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa and more
Alfasigma S.p.A.

Completed

Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease

Crohn's Disease

Israel, Italy, Russian Federation, Poland, Germany, France, Hungary
Genzyme, a Sanofi Company

Completed

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Crohn Disease

Switzerland, New Zealand, Canada, Australia, Brazil, Argentina, United Kingdom, Ukraine, Russian Federation
OSE Immunotherapeutics

Recruiting

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis (CoTikiS)

Ulcerative Colitis

Belgium, Latvia, Bulgaria, Belarus, Croatia, Georgia, Hungary, Poland, Russian Federation, South Africa, Ukraine
Janssen Research & Development, LLC

Active, not recruiting

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease (UNITI Jr)

Crohn Disease

United States, Israel, Belgium, Hungary, Japan, Germany, Poland, United Kingdom, Russian Federation
Janssen Research & Development, LLC

Terminated

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease (PRISM)

Crohn Disease

United States, Italy, Ukraine, Poland, Germany, Russian Federation, Argentina
Galapagos NV

Completed

Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

Crohn's Disease

United Kingdom, Belgium, France, Hungary, Russian Federation, Czech Republic, Germany, Poland, Romania
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Irritable Bowel Syndrome

Poland, Germany, Bulgaria, Ukraine, Estonia, Russian Federation, Czech Republic, Lithuania
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Acute Bacterial Skin and Skin Structure Infections

United States, Brazil, Bulgaria, Georgia, Germany, Guatemala, Latvia, Lithuania, Mexico, Poland, Russian Federation, South Africa, Turkey, Ukraine
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UNIFI)

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Australia, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Israel, Bulgaria, Romania, Serbia, Japan, Canada, Netherlands, Korea, Republic of, New Zealand, Russian Federation, Austria, Hungary, Slovakia, D... and more
Boehringer Ingelheim

Completed

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

Colitis, Ulcerative

Spain, United Kingdom, United States, Belgium, Germany, Italy, Austria, Canada, Japan, Korea, Republic of, Russian Federation, Poland

Clinical Trials on Stricture; Bowel in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations